Editorial Article
New lateral flow test may detect Alzheimer's decades early
Neuro-Bio is creating a first-of-its-kind diagnostic, targeting a novel biomarker in Alzheimer’s Disease
Products, services, reviews and techniques used in lead molecule testing in humans through clinical trials and regulatory services, and data analysis.
Neuro-Bio is creating a first-of-its-kind diagnostic, targeting a novel biomarker in Alzheimer’s Disease